Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 284
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02124239 | Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use Conditions | ||
| NCT04306315 | Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight | ||
| NCT07444801 | Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact | ||
| NCT02748902 | Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. | ||
| NCT03587805 | Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND | ||
| NCT01423656 | Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102 | ||
| NCT01083758 | Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis | ||
| NCT02411851 | Treatment of Actinic Keratoses (AK) on the Face | ||
| NCT00260988 | A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery | ||
| NCT03669757 | Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque Psoriasis | ||
| NCT01430312 | 21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation | ||
| NCT01257919 | Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea | ||
| NCT00617903 | Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea | ||
| NCT00626795 | Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL) | ||
| NCT00855595 | Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea | ||
| NCT01963793 | Topical Aprepitant in Prurigo Patients | ||
| NCT01105234 | An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects | ||
| NCT04883333 | A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults | ||
| NCT00216879 | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis | ||
| NCT01930396 | Use of Tinzaparin for Anticoagulation in Hemodialysis | ||
| NCT03514511 | Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis | ||
| NCT02377999 | Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts | ||
| NCT03556592 | Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4 | ||
| NCT00986856 | Fucidin® Cream in the Treatment of Impetigo | ||
| NCT01052467 | Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel) | ||
| NCT03958955 | Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus. | ||
| NCT01998984 | Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis | ||
| NCT05682352 | Investigating the Safety of LEO 158968 in Healthy Volunteers | ||
| NCT04203836 | A Trial to Evaluate the Effect of Food on LEO 152020 | ||
| NCT03115476 | A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp | ||
| NCT00185510 | Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis | ||
| NCT03114618 | A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient | ||
| NCT03358914 | The PsoTeenQOL - Preliminary Reliability and Validity | ||
| NCT01600014 | Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp | ||
| NCT03126578 | Open-label, Single Center, Non-randomized, Fixed Sequence Phase 1 Drug-drug Interaction Study With LEO 32731 and Midazolam | ||
| NCT00764751 | Efficacy and Safety of LEO 19123 Cream in the Treatment of Psoriasis Vulgaris | ||
| NCT01866163 | LEO 90100 Compared to Vehicle in Subjects With Psoriasis Vulgaris | ||
| NCT03054727 | Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT ) | ||
| NCT04794569 | Tinzaparin Lead-In to Prevent the Post-Thrombotic Syndrome | ||
| NCT05098821 | Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation | ||
| NCT04361136 | Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream | ||
| NCT02421471 | PMS to Evaluate the Safety and Efficacy of Picato® Gel | ||
| NCT01837576 | An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris | ||
| NCT02406014 | Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp | ||
| NCT00958516 | Assessment of the Phototoxic Potential of LEO 29102 Cream | ||
| NCT01836367 | Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp | ||
| NCT02126371 | LP0058-1005 - A Open-Label, Four-Way Crossover and Food-Effect Study of LEO 32731 in Healthy Subjects | ||
| NCT01422434 | LEO 90105 Ointment in Japanese Subjects With Psoriasis | ||
| NCT05625932 | TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer | ||
| NCT02547233 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up |
